Botswana News

The Government of Botswana observed World Antimicrobial Awareness Week 2024 (18–24 November) under the theme, “Educate, Advocate, Act Now”, at the Machaneng Main Kgotla in the Mahalapye District on 22 November 2024.

Botswana joined the global community in commemorating World AIDS Day on December 1, 2024, in Tlokweng village, with His Honour the Vice President Ndaba Gaolathe lauding the country’s achievements in surpassing the UNAIDS 95-95-95 fast-track targets. Botswana is recognized as a beacon of hope in the fight against HIV/AIDS, with 95% of individuals aged 15–65 living with HIV knowing their status, 98% of those diagnosed on Antiretroviral Therapy (ART), and 98% achieving viral suppression (95-98-98).

Botswana has ramped up its commitment to malaria elimination, convening a critical workshop in Palapye from December 16–20, 2024, to finalize the National Malaria Strategic Plan (NMSP) for 2025–2029. Supported by WHO Botswana, the five-day workshop brought together health experts, policymakers, and key stakeholders to develop a roadmap for achieving malaria-free status by 2029. Dr.

In honor of the 16 Days of Activism Against Gender-Based Violence-GBV, the WHO Botswana Country Office hosted a campaign featuring a video screening and discussion on GBV. A survivor shared a powerful story, highlighting key takeaways and exploring how WHO can contribute to ending GBV. Additionally, a pledge wall was set up for staff to write and share their commitments to addressing this issue.

Botswana has taken a significant step toward strengthening the governance of biological resources with the development of its National Policy on Access to Human Biological Material and Equitable Benefit-Sharing. This initiative, driven by the Ministry of Health (MoH) with support from the WHO Botswana Country Office, addresses critical gaps in managing biological resources, data sharing, and benefit distribution in healthcare and research.
The policy development process comprised three key phases. 

Botswana is making strides in combating HIV/AIDS through a comprehensive review of its National HIV Testing Services (HTS) Guidelines, conducted with support from the World Health Organization (WHO). The mission, spanning multiple sessions from June to September 2024, is a collaborative effort to align Botswana’s HIV testing strategies with the latest global recommendations, ensuring more targeted and effective intervention. 

On the 17th of September 2024, WHO country office in collaboration with other stakeholders including Meteorological Services, Southern African Science Service Centre for Climate Change and Adaptive Land Management (SASSCAL) and UNDP supported Ministry of Health in hosting a successful sensitization workshop under the theme” Role of Health Professionals on the Climate Change and Health”. The event gathered health professionals, policy makers, academia, researchers, and climate experts to address the urgent nexus between climate change and health in Botswana.

Botswana joined the global community in commemorating Patient Safety Day 2024 with a press briefing under the theme, "Improving Diagnosis for Patient Safety," accompanied by the slogan, "Get it Right, Make it Safe." The event focused on raising awareness of diagnostic errors, which are a significant contributor to patient harm, and highlighted the collective responsibility of healthcare stakeholders in ensuring safer care.

Environmental Surveillance (ES) was introduced in August 2022 to complement case-based AFP surveillance. The first established site for ES was Gaborone, Glen Valley Wastewater Treatment Site. Through this surveillance, the circulating Vaccine Derived Poliovirus type 2 (cVDPV2) was detected on October 4, 2022. Following the country risk assessment, a recommendation was made to conduct a nationwide vaccination campaign using the novel polio type 2 polio vaccine (nOPV2) for all children under the age of 7.

Polio remains a critical global public health concern, particularly with the resurgence of circulating vaccine-derived poliovirus type 2 (cVDPV2). In Botswana, the detection of cVDPV2 in environmental surveillance in 2022 and 2023 highlighted vulnerabilities in population immunity. In response, the Botswana National Immunization Technical Advisory Group, BOTSNITAG conducted a rigorous review of scientific evidence, concluding that introducing a second IPV dose would substantially increase immunity among children under two years of age.